BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2621180)

  • 21. The induction of trimethoprim resistance encoded by the type IV dihydrofolate reductase gene.
    Young HK; Thomson CJ; Amyes SG
    J Med Microbiol; 1993 Apr; 38(4):256-61. PubMed ID: 8474117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New observations regarding evolution of trimethoprim resistance.
    Tennhammar-Ekman B; Sundström L; Sköld O
    J Antimicrob Chemother; 1986 Oct; 18 Suppl C():67-76. PubMed ID: 3804898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trimethoprim resistance in Escherichia coli isolates from a geriatric unit.
    Heikkilä E; Sundström L; Huovinen P
    Antimicrob Agents Chemother; 1990 Oct; 34(10):2013-5. PubMed ID: 2291668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular characterization of trimethoprim resistance in salmonellas isolated in Sicily, 1985-1988.
    Agodi A; Marranzano M; Jones CS; Threlfall EJ
    Eur J Epidemiol; 1995 Feb; 11(1):33-8. PubMed ID: 7489771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple mutations modulate the function of dihydrofolate reductase in trimethoprim-resistant Streptococcus pneumoniae.
    Maskell JP; Sefton AM; Hall LM
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1104-8. PubMed ID: 11257022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trimethoprim-resistant Enterobacteriaceae in urinary tract infection.
    Wong CK; Harding GK; Ronald AR; Hoban S
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):54-8. PubMed ID: 1093652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and cloning of the type IIIa plasmid-encoded dihydrofolate reductase gene from trimethoprim-resistant gram-negative bacteria isolated in Britain.
    Thomson CJ; Towner KJ; Young HK; Amyes SG
    J Med Microbiol; 1990 Mar; 31(3):213-8. PubMed ID: 2179557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation and characterization of dihydrofolate reductase from trimethoprim-susceptible and trimethoprim-resistant Pseudomonas cepacia.
    Burns JL; Lien DM; Hedin LA
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1247-51. PubMed ID: 2802552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of transposons encoding kanamycin, ampicillin and trimethoprim resistance in isolates from urinary tract infections detected using DNA probes.
    Chang SF; Chang LL; Chow TY; Wu WJ; Chang JC
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Mar; 8(3):141-7. PubMed ID: 1313888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasmid-mediated trimethoprim-resistance in Staphylococcus aureus. Characterization of the first gram-positive plasmid dihydrofolate reductase (type S1).
    Young HK; Skurray RA; Amyes SG
    Biochem J; 1987 Apr; 243(1):309-12. PubMed ID: 3606580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A follow-up survey of transferable, plasmid-encoded trimethoprim resistance in a general hospital (1975-1983).
    Chirnside ED; Emmerson AM; Smith JT
    J Antimicrob Chemother; 1985 Oct; 16(4):419-34. PubMed ID: 4066558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a novel plasmid-encoded dihydrofolate reductase mediating high-level resistance to trimethoprim.
    Wylie BA; Amyes SG; Young HK; Koornhof HJ
    J Antimicrob Chemother; 1988 Oct; 22(4):429-35. PubMed ID: 3060457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The antimicrobial activities of trimethoprim and sulfonamides.
    Burman LG
    Scand J Infect Dis; 1986; 18(1):3-13. PubMed ID: 3515508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Characterization of trimethoprim resistance in Shigella].
    Chang LL; Chen HL; Chang CY; Chang SF
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1993 Dec; 9(12):676-83. PubMed ID: 8207766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trimethoprim resistance determinants encoding a dihydrofolate reductase in clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci.
    Tennent JM; Young HK; Lyon BR; Amyes SG; Skurray RA
    J Med Microbiol; 1988 May; 26(1):67-73. PubMed ID: 3373516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trimethoprim resistance; epidemiology and molecular aspects.
    J Med Microbiol; 1990 Jan; 31(1):1-19. PubMed ID: 2404123
    [No Abstract]   [Full Text] [Related]  

  • 37. Antimicrobial resistance of Gram-negative bacilli isolates from inpatients and outpatients at Yaounde Central Hospital, Cameroon.
    Piéboji JG; Koulla-Shiro S; Ngassam P; Adiogo D; Njine T; Ndumbe P
    Int J Infect Dis; 2004 May; 8(3):147-54. PubMed ID: 15109589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of the Molecular Mechanism of Trimethoprim Resistance in Listeria monocytogenes.
    Korsak D; Krawczyk-Balska A
    Foodborne Pathog Dis; 2017 Dec; 14(12):696-700. PubMed ID: 28910155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activity of the combination trimethoprim plus sulfamethoxazole compared with that of other chemotherapeutic agents.
    Focht J; Klietmann W; Nösner K
    Arzneimittelforschung; 1988 Aug; 38(8):1085-8. PubMed ID: 3264166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacterial profile and drug susceptibility pattern of urinary tract infection in pregnant women at Tikur Anbessa Specialized Hospital Addis Ababa, Ethiopia.
    Assefa A; Asrat D; Woldeamanuel Y; G/Hiwot Y; Abdella A; Melesse T
    Ethiop Med J; 2008 Jul; 46(3):227-35. PubMed ID: 19271386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.